Menu
September 25-26, 2025
Sydney, Nova Scotia
The Accelerating Clinical Trials Consortium met September 25-26, 2025 in Sydney, Nova Scotia to explore international developments and collaboration opportunities in clinical trials.
Highlights from the agenda include:
- Exploring alternative patient consent, and permission to contact models
- Discussions around improving access to trials for people who have been
historically excluded - Updates on ACT-supported high-impact, high-quality clinical trials
- Planning the future of the Canadian clinical trials landscape
Registration for the conference is now closed.
For more information contact us at: act.canada@phri.ca
- ACT Canada Report Card & Goals of meeting
- WHO Global action plan for clinical trial ecosystem strengthening
- From Principles to Practice: Ethics of Consent Models in Clinical Trials
- Innovations in Consent: Modifications and Alternative Models in Clinical Trials
- Exploring Alternative Consent Models Across Trials: Findings and Reflections
- STRATUS Randomized Clinical Trial
- TRACTION Trial
- DIALEX Trial
- Breakout groups’ summary reports
- REFINE-ICD results
- CLEAR Trial results
- B-free results
- Patient Experience – New Brunswick Cancer Patient
- Indigenous Clinical Trial Research – Insights, Opportunities, and the Path Forward: A Dialogue
- The time is right to invest in Canadian biotechnology and stop subsidizing foreign biotechnology companies
- Removing barriers to inclusion of pregnant and lactating women and women of childbearing potential in clinical trials
- Removing barriers to inclusion of patients with renal impairment in clinical trials
- IDEA Toolkit Launch
- Breakout groups’ summary reports
- Update on CanReview
- Initiatives to Facilitate Research at HHS
- Reflections on the future for RCTs at CIHR
- Developing LMWH – from lab to FDA approval, and the first adequately powered study showing aspirin is effective in partial stroke
- Update on ACT 2 proposal
- Update on ACT contracts
